DCASIP and DASON fellow, Mike Yarrington, worked with the DASON faculty and staff to analyze antibiotic use data from 29 southeastern US hospitals over a 5-year period to determine changes in antibiotic use after the fluoroquinolone US Food and Drug Administration (FDA) advisory update in 2016. Fluoroquinolone use declined both before and after the FDA announcement, and the use of select, alternative antibiotics increased after the announcement.
DCASIP Director, and DASON Co-Founder, Dr. Dev Anderson, et al, tested two core antimicrobial stewardship interventions at four community hospitals in the DASON network. The details of the study can be found on JAMA Network Open. They found that one of the care interventions -- post-prescription audit and review by a pharmacist after 72 house of therapy -- was feasible in facilities with limited resources and little to no antimicrobial stewardship expertise.
On May 28, 2019 a paper that DASON staff, DCASIP faculty, and Duke Health Pharmacy staff have been working on was published in Infection Control & Hospital Epidemiology. The purpose of this work was to assess the feasibility of electronic data capture of post discharge durations and evaluate total durations of anyimicrobial exposure related to inpatient hospital stays.
To read the full publication, click here.
In December, we announced that three of our DASON hospitals are participating in the STewardship of Antimicrobial Resources (STAR) Partners Initiative, which is part of the A part of the NC SHARPPS program. Check out the original announcement here.
The impact of an effective antimicrobial stewardship on patient safety, better patient outcomes, hospital costs, and reducing antimicrobial resistance are enormous.
The resources and support we have received from DASON have allowed us to move projects forward in our antimicrobial stewardship efforts much more quickly and effectively than we could ever have done on our own.